ClinicalTrials.gg
Not yet recruitingNCT05425017CrUSUpdated Nov 10, 2026

Analysis of Crepitus in Human Subjects

An observational study in Low Back Pain and Healthy, sponsored by National University of Health Sciences. Not yet recruiting at 3 sites in United States. Open to participants aged 30 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by National University of Health Sciences · Observational

How we know

Updated Nov 10, 2026Now Not yet recruitingStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
30 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Planned enrollment
73rd of 85
12 · median 90
Started
2026
with 32 others
Observational
87 of 712
19 open now
Primary completion
2027-12
later than 86 of 125 live
Registered
564th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 73rd largest by planned enrollment of the 85 observational ones that give a count, is one of 33 that started in 2026, is one of 87 observational ones, reaches primary completion later than 86 of the 125 other live ones, and was the 564th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

95 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 30 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

Chiropractic adjustment has been shown to gap certain joints in the spine, thereby improving mobility in individuals with decreased movement capabilities. During normal motion, joints in the spine produce sounds and vibrations called crepitus. The purpose of this study is to assess how this crepitus may be used as an indicator for joint degeneration in healthy human subjects and those with low back pain, and if chiropractic adjusting causes change in this crepitus. The investigators hypothesize that change in crepitus after adjustment may be a useful indication of changes in joint mobility and joint stiffness.

Read the detailed description

Objective: This is an expansion of the initial study "Analysis of Crepitus in Human Subjects" to assess the feasibility of simultaneously recording zygapophyseal (Z) joint crepitus using piezoelectric accelerometers and Z joint motion using diagnostic ultrasound (US), and qualitatively assess the US images with particular focus on images taken of Z joints exhibiting crepitus. Like the original study (n=12), the results of a recently developed automated method (AM) is compared with two human observers in the analysis of recordings of human lumbar zygapophyseal (Z) joint crepitus. The recordings will be taken during ranges of motion performed before and after lumbar side-posture spinal manipulation (SMT). Methods: Six (6) healthy and 6 low back pain subjects will participate in the study. Using clinical study procedures developed previously, subjects will be given an initial phone screen before being scheduled for a clinical study appointment. At the appointment, subjects will undergo the informed consent process, and those consenting will be further screened and examined by the Research Clinician who will use the inclusion/exclusion criteria to determine eligibility for the study. Eligible subjects will be enrolled and scheduled for an accelerometry visit. At the accelerometry visit, 11 accelerometers will be applied to the lumbar region, allowing assessment of Z joint crepitus. US imaging of the right L4/L5 Z joint will be included. Each subject will undergo full flexion and full extension (ROM) while recordings are made from the accelerometers. Subjects will then undergo bilateral lumbar SMT, and immediately thereafter will undergo repeated ROM while recordings are made. Two human observers and the AM, blinded to the results of one another, will then assess the recordings to identify Z joints from which crepitus originated. The primary outcomes will be: 1) weighted kappa inter-rater reliability statistic comparing AM and the 2 human observers in identifying Z joint crepitus, and 2) ANOVA test statistic comparing time to complete the crepitus analysis by the AM and human observers. Hypotheses: 1) The automated method will be reliable, agreeing with the human observers' analysis. 2) The automated method will be significantly more time efficient than the analyses made by the human observers. Application: The investigators believe that this program will improve the efficiency of identifying the site of Z joint crepitus, thereby advancing the line of investigation designed to use crepitus as a biomarker of spinal joint dysfunction.

03

Conditions studied

  • Low Back Pain
  • Healthy

Browse trials for

Keywords

  • crepitus
  • spine
  • noise
  • physiological
  • pathological
04

Who can participate

Ages eligible
30 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will be recruited from the faculty, student and staff population at National University Of Health Sciences, Lombard, IL. If unable to recruit sufficient number of participants, recruitment will be extended to the general population of the Chicago, IL metro area.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy (no LBP) Subjects (n=6):

  • 30 to 75 years of age
  • No previous history of LBP lasting for more than two weeks, or no more than three episodes of back pain of brief duration (one week) in any given year (to recruit healthy subjects with no history, or a minimal history, of LBP).
  • No presence of current LBP
  • Female with a of 28 or less; Male with a BMI of 30 or less.

LBP Subjects Criteria (n=6):

  • 30 to 75 years of age
  • Current LBP of at least one-week (7 days) duration
  • Female with a BMI of 28 or less; Male with a BMI of 30 or less.

Exclusion criteria

Exclusion Criteria:

Healthy Subjects:

  • Under 30 or over 75 years of age
  • History of an episode of LBP lasting for more than two weeks, or more than three episodes of back pain of brief duration (one week) in any given year (see reasons for no LBP in Inclusion Criteria)
  • Presence of Current LBP
  • Prior spinal surgery
  • Presence of current spinal fracture, tumor, infection, or scoliosis of greater than 5 degrees (Cobb's angle, scoliosis decreases ability to place the accelerometers); or other known significant pathology
  • Known allergies to latex or adhesives (including Band-Aids) applied to the skin (accelerometers are taped to the skin)
  • over 30 for males; BMI over 28 for females (subject will be weighed at exam)
  • Pregnancy (because of unique biomechanical patterns and changes in the ranges of motion that occur during pregnancy)
  • Positive findings on any of the orthopedic or neurological tests listed on exam form; (because these subjects will be assessed as healthy individuals, indication of somatic pathology or neurological deficit are exclusionary criteria)
  • Decreased range of motion (as measured with a goniometer) of the lumbar region (recording during flexion and extension ranges of motion are conducted in the study; consequently a full range of motion is necessary for the healthy subjects). The following ranges will be exclusionary: Flexion: \< 40º (normal = 60º); Extension: \< 10º (normal = 20º);
  • Pain or discomfort during set-up for lumbar side-posture spinal manipulation (SMT) or during lumbar SMT given at the conclusion of the examination (the study assesses changes following SMT, consequently ability to tolerate SMT is important)
  • to manipulative treatment

LBP Subjects:

  • Under 30 or over 75 years of age
  • Absence of Current LBP of at least one-week (7 days) duration
  • BMI over 30 for males; BMI over 28 for females (subject will be weighed at exam)
  • Known allergies to latex or adhesives (including Band Aids) applied to the skin (accelerometers are taped to the skin)
  • Pregnancy (because of unique biomechanical patterns and changes in the ranges of motion that occur during pregnancy)
  • Pain radiating below the knee
  • Presence of current spinal fracture, tumor, infection, or scoliosis of greater than 5 degrees (Cobb's angle, scoliosis decreases ability to place the accelerometers); or other known significant pathology
  • Prior spinal surgery
  • Negative findings on all of the orthopedic or neurological tests listed on exam form
  • Contraindication to manipulative treatment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Patient registry
No

Groups and cohorts

  • Low back pain group

    Participants currently experiencing low back pain will have small accelerometers taped along spine, Ultrasound (US) Clinician will place an US transducer at the right L4/L5 Z joint. Participants will complete a range of motions while accelerometers are recording back sounds. Subsequently, they will receive a chiropractic adjustment, then repeat the range of motions

  • Healthy group

    Participants without low back pain will have small accelerometers taped along spine. Ultrasound (US) Clinician will place a US transducer at the right L4/L5 Z joint. Participants will perform a range of motions while accelerometers are recording back sounds. Subsequently, they will receive a chiropractic adjustment, then repeat the range of motions

    Other: Range of motion with spinal adjustment

Interventions

  • OtherRange of motion with spinal adjustment

    With accelerometers affixed to spine recording vibrations, the participants complete range of motion. After completing, they receive a low back spinal adjustment and repeat range of motion

06

What researchers measure

Primary outcomes

  1. Inter-rater reliability of analysis of spinal crepitus produced during range of motion

    Piezoelectric accelerometers are taped to the participants spine. The participant then completes a range of motions while the accelerometers are recording any sounds being produced during the movement. Following range of motion, the participant receives a side posture chiropractic adjustment and then repeats the range of motion while the accelerometers are recording. All participant recordings will be collected prior to the start of analysis. Utilizing previously validated methods to analyze accelerometer recordings taken during participants range of motion, spinal crepitus will be identified and defined and programmed into a computer automated method of analysis. Kappa inter-rater reliability statistic will be compare consensus of two human observers to the computer automated method of analysis will be compared.

    Time frame: 6 month following data collection

  2. Time of analysis of spinal crepitus produced during range of motion

    Piezoelectric accelerometers are taped to the participants spine. The participant then completes a range of motions while the accelerometers are recording any sounds being produced during the movement. Following range of motion, the participant receives a side posture chiropractic adjustment and then repeats the range of motion while the accelerometers are recording. All participant recordings will be collected prior to the start of analysis. Utilizing previously validated methods to analyze accelerometer recordings taken during participants range of motion, spinal crepitus will be identified and defined and programmed into a computer automated method of analysis. The time it takes to complete analysis of all crepitus recordings will be compared by ANOVA between two human observers and the computer automated method of analysi

    Time frame: 6 month following data collection

Secondary outcomes

  1. Change in crepitus following spinal manipulation

    Piezoelectric accelerometers are taped to the participants spine. The participant then completes a range of motions while the accelerometers are recording any sounds being produced during the movement. Following range of motion, the participant receives a side posture chiropractic adjustment and then repeats the range of motion while the accelerometers are recording. For each participant, crepitus produced during range of motion performed prior to chiropractic adjustment will be compared to crepitus produced following chiropractic adjustment. All participant recordings will be collected prior to the start of analysis. Ultrasound outcomes will be subjective and descriptive to identify imaging of the right L4/L5 Z joint.

    Time frame: 6 month following data collection

07

Study locations

3 sites
  • National University of Health Sciences
    Lombard, Illinois 60148, United States
  • National University of Health Science
    Lombard, Illinois 60148, United States
    • Jocelyn Faydenko, ND, DC · Contactjfaydenko@nuhs.edu · 6308896420
    • Gregory Cramer, DC, PhD · Contactgcramer@nuhs.edu · 6308896536
    • Gregory Cramer, DC, PhD · Principal investigator
  • National University of Health Science
    Lombard, Illinois 60148, United States
08

References and documents

Publications

  • Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, Williams G, Smith E, Vos T, Barendregt J, Murray C, Burstein R, Buchbinder R. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014 Jun;73(6):968-74. doi: 10.1136/annrheumdis-2013-204428. Epub 2014 Mar 24. PubMed 24665116 ↗
  • Bronfort G, Haas M, Evans RL, Bouter LM. Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis. Spine J. 2004 May-Jun;4(3):335-56. doi: 10.1016/j.spinee.2003.06.002. PubMed 15125860 ↗
  • Chou R, Huffman LH; American Pain Society; American College of Physicians. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007 Oct 2;147(7):492-504. doi: 10.7326/0003-4819-147-7-200710020-00007. PubMed 17909210 ↗
  • Schneider M, Haas M, Glick R, Stevans J, Landsittel D. Comparison of spinal manipulation methods and usual medical care for acute and subacute low back pain: a randomized clinical trial. Spine (Phila Pa 1976). 2015 Feb 15;40(4):209-17. doi: 10.1097/BRS.0000000000000724. PubMed 25423308 ↗
  • Fritz JM, Kim J, Dorius J. Importance of the type of provider seen to begin health care for a new episode low back pain: associations with future utilization and costs. J Eval Clin Pract. 2016 Apr;22(2):247-52. doi: 10.1111/jep.12464. Epub 2015 Sep 29. PubMed 26417660 ↗
  • Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Int J Ther Massage Bodywork. 2015 Sep 1;8(3):16-33. doi: 10.3822/ijtmb.v8i3.295. eCollection 2015 Sep. PubMed 26388962 ↗
  • Rubinstein SM, Terwee CB, Assendelft WJ, de Boer MR, van Tulder MW. Spinal manipulative therapy for acute low-back pain. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD008880. doi: 10.1002/14651858.CD008880.pub2. PubMed 22972127 ↗
  • Deyo RA, Bryan M, Comstock BA, Turner JA, Heagerty P, Friedly J, Avins AL, Nedeljkovic SS, Nerenz DR, Jarvik JG. Trajectories of symptoms and function in older adults with low back disorders. Spine (Phila Pa 1976). 2015 Sep 1;40(17):1352-62. doi: 10.1097/BRS.0000000000000975. PubMed 25996537 ↗
  • Brennan GP, Fritz JM, Hunter SJ, Thackeray A, Delitto A, Erhard RE. Identifying subgroups of patients with acute/subacute "nonspecific" low back pain: results of a randomized clinical trial. Spine (Phila Pa 1976). 2006 Mar 15;31(6):623-31. doi: 10.1097/01.brs.0000202807.72292.a8. PubMed 16540864 ↗
  • Cramer GD, Ross JK, Raju PK, Cambron JA, Dexheimer JM, Bora P, McKinnis R, Selby S, Habeck AR. Distribution of cavitations as identified with accelerometry during lumbar spinal manipulation. J Manipulative Physiol Ther. 2011 Nov;34(9):572-83. doi: 10.1016/j.jmpt.2011.05.015. Epub 2011 Jul 18. PubMed 21986305 ↗
  • Cramer GD, Ross K, Pocius J, Cantu JA, Laptook E, Fergus M, Gregerson D, Selby S, Raju PK. Evaluating the relationship among cavitation, zygapophyseal joint gapping, and spinal manipulation: an exploratory case series. J Manipulative Physiol Ther. 2011 Jan;34(1):2-14. doi: 10.1016/j.jmpt.2010.11.008. PubMed 21237402 ↗
  • Cramer GD, Budavich M, Bora P, Ross K. A Feasibility Study to Assess Vibration and Sound From Zygapophyseal Joints During Motion Before and After Spinal Manipulation. J Manipulative Physiol Ther. 2017 Mar-Apr;40(3):187-200. doi: 10.1016/j.jmpt.2017.01.003. Epub 2017 Mar 6. PubMed 28268027 ↗
  • Cramer GD, Ross K, Raju PK, Cambron J, Cantu JA, Bora P, Dexheimer JM, McKinnis R, Habeck AR, Selby S, Pocius JD, Gregerson D. Quantification of cavitation and gapping of lumbar zygapophyseal joints during spinal manipulative therapy. J Manipulative Physiol Ther. 2012 Oct;35(8):614-21. doi: 10.1016/j.jmpt.2012.06.007. Epub 2012 Aug 14. PubMed 22902194 ↗
  • Lascelles BD, Dong YH, Marcellin-Little DJ, Thomson A, Wheeler S, Correa M. Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in cats. BMC Vet Res. 2012 Jan 27;8:10. doi: 10.1186/1746-6148-8-10. PubMed 22281125 ↗
  • Abhishek A, Doherty M. Diagnosis and clinical presentation of osteoarthritis. Rheum Dis Clin North Am. 2013 Feb;39(1):45-66. doi: 10.1016/j.rdc.2012.10.007. PubMed 23312410 ↗
  • Robertson CJ. Joint crepitus--are we failing our patients? Physiother Res Int. 2010 Dec;15(4):185-8. doi: 10.1002/pri.492. Epub 2010 Oct 28. No abstract available. PubMed 21031637 ↗
  • Henderson CN, Cramer GD, Zhang Q, DeVocht JW, Fournier JT. Introducing the external link model for studying spine fixation and misalignment: part 2, Biomechanical features. J Manipulative Physiol Ther. 2007 May;30(4):279-94. doi: 10.1016/j.jmpt.2007.03.002. PubMed 17509437 ↗
  • Cramer GD, Henderson CN, Little JW, Daley C, Grieve TJ. Zygapophyseal joint adhesions after induced hypomobility. J Manipulative Physiol Ther. 2010 Sep;33(7):508-18. doi: 10.1016/j.jmpt.2010.08.002. PubMed 20937429 ↗
  • Roytman G, Faydenko J, Budavich M, Pocius JD, Cramer G. Automated Vibration and Acoustic Crepitus Sensing in Humans. J. Tribol. Sept 2023, 145 (9)

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 12 months is below that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Sep 2024 → Dec 2026, primary completion Jun 2025 → Dec 2027 and completion Dec 2025 → Jun 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2022
First posted
Jun 21, 2022
StartEst.
Dec 1, 2026was Sep 2024
Primary completionEst.
Dec 2027was Jun 2025
CompletionEst.
Jun 1, 2028was Dec 2025
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Not yet recruiting
changed Nov 10, 2026
Sites
1 site added
Show site
  • National University of Health Science · Lombard, United States
Nov 10, 2026
Start date
Sep 1, 2024→Dec 1, 2026
Nov 10, 2026
Primary completion
Jun 30, 2025→Dec 2027
Nov 10, 2026
Study completion
Dec 1, 2025→Jun 1, 2028
Nov 10, 2026
Contact
Study contact now listed: added j•••@nuhs.edu · •••6849; added g•••@nuhs.edu · •••6849. See the current contact
Nov 10, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • National University of Health Science · Lombard, United StatesContact added j•••@nuhs.edu · •••6420Contact added g•••@nuhs.edu · •••6536Contact added (no phone or email listed)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Active, not recruiting→Not yet recruiting
    1 site added
    Show site
    • National University of Health Science · Lombard, United States
    Start date Sep 1, 2024→Dec 1, 2026
    Primary completion Jun 30, 2025→Dec 2027
    Study completion Dec 1, 2025→Jun 1, 2028
    Contact Study contact now listed: added j•••@nuhs.edu · •••6849; added g•••@nuhs.edu · •••6849. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • National University of Health Science · Lombard, United StatesContact added j•••@nuhs.edu · •••6420Contact added g•••@nuhs.edu · •••6536Contact added (no phone or email listed)
    + 2 other changes: verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05425017
Lead sponsor
National University of Health Sciences
Collaborators
Yale University
Responsible party
Gregory D. Cramer (Professor and Dean of Research, National University of Health Sciences) — Principal investigator
First posted
Jun 21, 2022
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Nov 10, 2026

Study contacts

Jocelyn Faydenko, ND, DC
Contact
jfaydenko@nuhs.edu
630-889-6849
Gregory Cramer, DC, PhD
Contact
gcramer@nuhs.edu
630-889-6849
Gregory Cramer, DC, PhD
principal investigator · National University of Health Sciences
Gregory Roytman, DC
principal investigator · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion